International Journal of Clinical Oncology

, Volume 23, Issue 2, pp 314–320 | Cite as

Radiotherapy for vaginal cancer: a multi-institutional survey study of the Japanese Radiation Oncology Study Group

  • Hitoshi IkushimaEmail author
  • Masaru Wakatsuki
  • Takuro Ariga
  • Yuko Kaneyasu
  • Sunao Tokumaru
  • Fumiaki Isohashi
  • Noriko Ii
  • Takashi Uno
  • Tatsuya Ohno
  • Kokichi Arisawa
  • Takafumi Toita
Original Article



Our aim was to assess the patterns of practice and treatment outcomes of definitive radiotherapy (RT) for vaginal cancer in Japan.

Materials and methods

RT methods and outcomes of patients with vaginal cancer treated with definitive RT or chemoradiotherapy at 10 institutes of the Japanese Radiation Oncology Study Group between January 2000 and March 2010 were retrospectively evaluated.


A total of 90 patients were enrolled in the study. The clinical stages were I, II, III, and IVA in 34, 36, 16, and 4 patients, respectively. Seventy patients were treated with three-dimensional conformal RT (3DCRT) and brachytherapy (BT), 12 with BT alone, and 8 with 3DCRT alone. Chemotherapy was administered to 29 patients. The 5-year overall survival and local control rates were 77 and 83% with a median follow-up period of 94 months for surviving or lost patients. The 5-year overall survival rates according to stage were 94, 71, 56, and 75% for stages I, II, III, and IVA, respectively. The 5-year local control rates according to stage were 94, 77, 74, and 75% for stages I, II, III, and IVA, respectively. Twenty-nine percent (6 of 21 patients) of local recurrences occurred between 5 and 10 years after RT. The 10-year local control rate of all patients was 71%. Significant prognostic factors for overall survival by univariate and multi-variate analyses were performance status, tumor size, and pelvic lymph node metastasis. Grade 3 late radiation morbidity of the rectum, pelvic bone, urinary bladder, and skin developed in 9% (8 of 90 patients).


Good outcomes similar to those of cervical cancer can be achieved with definitive RT delivered by 3DCRT and/or BT for vaginal cancer. Long follow-up is necessary for a continuing risk of local recurrence after 5 years.


Brachytherapy Chemoradiotherapy Radiotherapy Vaginal cancer 


Compliance with ethical standards

Conflict of interest

The authors declare that there are no conflicts of interest.


  1. 1.
    Wu X, Matanoski G, Chen VW et al (2008) Descriptive epidemiology of vaginal cancer incidence and survival by race, ethnicity, and age in the United States. Cancer 113:2873–2882CrossRefPubMedGoogle Scholar
  2. 2.
    Creasman WT, Phillips JL, Menck HR (1998) The National Cancer Data Base report on cancer of the vagina. Cancer 83:1033–1040CrossRefPubMedGoogle Scholar
  3. 3.
    Chyle V, Zagars GK, Wheeler JA et al (1996) Definitive radiotherapy for carcinoma of the vagina: outcome and prognostic factors. Int J Radiat Oncol Biol Phys 35:891–905CrossRefPubMedGoogle Scholar
  4. 4.
    de Crevoisier R, Sanfilippo N, Gerbaulet A et al (2007) Exclusive radiotherapy for primary squamous cell carcinoma of the vagina. Radiother Oncol 85:362–370CrossRefPubMedGoogle Scholar
  5. 5.
    Frank SJ, Jhingran A, Levenback C, Eifel PJ (2005) Definitive radiation therapy for squamous cell carcinoma of the vagina. Int J Radiat Oncol Biol Phys 62:138–147CrossRefPubMedGoogle Scholar
  6. 6.
    Hegemann S, Schafer U, Lelle R et al (2009) Long-term results of radiotherapy in primary carcinoma of the vagina. Strahlenther Onkol 185:184–189CrossRefPubMedGoogle Scholar
  7. 7.
    Hiniker SM, Roux A, Murphy JD et al (2013) Primary squamous cell carcinoma of the vagina: prognostic factors, treatment patterns, and outcomes. Gynecol Oncol 131:380–385CrossRefPubMedGoogle Scholar
  8. 8.
    Kirkbride P, Fyles A, Rawlings GA et al (1995) Carcinoma of the vagina—experience at the Princess Margaret Hospital (1974–1989). Gynecol Oncol 56:435–443CrossRefPubMedGoogle Scholar
  9. 9.
    Kucera H, Vavra N (1991) Radiation management of primary carcinoma of the vagina: clinical and histopathological variables associated with survival. Gynecol Oncol 40:12–16CrossRefPubMedGoogle Scholar
  10. 10.
    Lian J, Dundas G, Carlone M et al (2008) Twenty-year review of radiotherapy for vaginal cancer: an institutional experience. Gynecol Oncol 111:298–306CrossRefPubMedGoogle Scholar
  11. 11.
    Miyamoto DT, Viswanathan AN (2013) Concurrent chemoradiation for vaginal cancer. PLoS One 8:e65048CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Perez CA, Grigsby PW, Garipagaoglu M et al (1999) Factors affecting long-term outcome of irradiation in carcinoma of the vagina. Int J Radiat Oncol Biol Phys 44:37–45CrossRefPubMedGoogle Scholar
  13. 13.
    Platta CS, Anderson B, Geye H et al (2013) Adjuvant and definitive radiation therapy for primary carcinoma of the vagina using brachytherapy and external beam radiation therapy. J Contemp Brachytherapy 5:76–82CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Tran PT, Su Z, Lee P et al (2007) Prognostic factors for outcomes and complications for primary squamous cell carcinoma of the vagina treated with radiation. Gynecol Oncol 105:641–649CrossRefPubMedGoogle Scholar
  15. 15.
    Hellman K, Lundell M, Silfversward C et al (2006) Clinical and histopathologic factors related to prognosis in primary squamous cell carcinoma of the vagina. Int J Gynecol Cancer 16:1201–1211CrossRefPubMedGoogle Scholar
  16. 16.
    Tabata T, Takeshima N, Nishida H et al (2002) Treatment failure in vaginal cancer. Gynecol Oncol 84:309–314CrossRefPubMedGoogle Scholar
  17. 17.
    Cox JD, Stetz J, Pajak TF (1995) Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31:1341–1346CrossRefPubMedGoogle Scholar
  18. 18.
    Moran MS, Castrucci WA, Ahmad M et al (2010) Clinical utility of the modified segmental boost technique for treatment of the pelvis and inguinal nodes. Int J Radiat Oncol Biol Phys 76:1026–1036CrossRefPubMedGoogle Scholar
  19. 19.
    Beriwal S, Demanes DJ, Erickson B et al (2012) American Brachytherapy Society consensus guidelines for interstitial brachytherapy for vaginal cancer. Brachytherapy 11:68–75CrossRefPubMedGoogle Scholar
  20. 20.
    Kucera H, Mock U, Knocke TH et al (2001) Radiotherapy alone for invasive vaginal cancer: outcome with intracavitary high dose rate brachytherapy versus conventional low dose rate brachytherapy. Acta Obstet Gynecol Scand 80:355–360CrossRefPubMedGoogle Scholar
  21. 21.
    Dalrymple JL, Russell AH, Lee SW et al (2004) Chemoradiation for primary invasive squamous carcinoma of the vagina. Int J Gynecol Cancer 14:110–117CrossRefPubMedGoogle Scholar
  22. 22.
    Samant R, Lau B, Choan E et al (2007) Primary vaginal cancer treated with concurrent chemoradiation using Cis-platinum. Int J Radiat Oncol Biol Phys 69:746–750CrossRefPubMedGoogle Scholar
  23. 23.
    Daling JR, Madeleine MM, Schwartz SM et al (2002) A population-based study of squamous cell vaginal cancer: HPV and cofactors. Gynecol Oncol 84:263–270CrossRefPubMedGoogle Scholar
  24. 24.
    Ghia AJ, Gonzalez VJ, Tward JD et al (2011) Primary vaginal cancer and chemoradiotherapy: a patterns-of-care analysis. Int J Gynecol Cancer 21:378–384CrossRefPubMedGoogle Scholar

Copyright information

© Japan Society of Clinical Oncology 2017

Authors and Affiliations

  • Hitoshi Ikushima
    • 1
    Email author
  • Masaru Wakatsuki
    • 2
    • 3
  • Takuro Ariga
    • 4
  • Yuko Kaneyasu
    • 5
    • 6
  • Sunao Tokumaru
    • 7
    • 8
  • Fumiaki Isohashi
    • 9
  • Noriko Ii
    • 10
  • Takashi Uno
    • 11
  • Tatsuya Ohno
    • 12
  • Kokichi Arisawa
    • 13
  • Takafumi Toita
    • 4
  1. 1.Department of Therapeutic RadiologyTokushima University Graduate SchoolTokushimaJapan
  2. 2.Department of RadiologyJichi Medical UniversityShimotsukeJapan
  3. 3.National Institutes for Quantum and Radiological Science and TechnologyChibaJapan
  4. 4.Department of Radiology, Graduate School of Medical ScienceUniversity of the RyukyusNakagamiJapan
  5. 5.National Hospital Organization Fukuyama Medical CenterFukuyamaJapan
  6. 6.Department of Radiation OncologyHiroshima UniversityHigashihiroshimaJapan
  7. 7.Hyogo Ion Beam Medical CenterTatsunoJapan
  8. 8.Department of RadiologySaga UniversitySagaJapan
  9. 9.Department of Radiation OncologyOsaka University Graduate School of MedicineSuitaJapan
  10. 10.Department of Radiation OncologyMie University HospitalTsuJapan
  11. 11.Diagnostic Radiology and Radiation Oncology, Graduate School of MedicineChiba UniversityChibaJapan
  12. 12.Gunma University Heavy Ion Medical CenterMaebashiJapan
  13. 13.Department of Preventive MedicineTokushima University Graduate SchoolTokushimaJapan

Personalised recommendations